Imagenebio, Inc. (IMA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imagenebio, Inc., a Delaware corporation, on June 26, 2026, covering events occurring on June 22, 2026. The company is an emerging growth company with its principal executive offices in San Diego, California, and its common stock trades on The Nasdaq Capital Market under the symbol "IMA".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of a senior executive:
- Resignation: Robert Lally, Senior Vice President of Finance and Operations and Principal Accounting Officer, resigned effective July 22, 2026.
- Reason: The resignation was not due to any disagreement with the Company.
- Succession: The Company plans to conduct a search for Mr. Lally's replacement.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the operational impact of the executive departure. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Principal Accounting Officer and Senior Vice President of Finance.
- Review subsequent filings for any interim financial reporting arrangements during the transition period.
- Monitor for any changes in the company's internal controls over financial reporting resulting from the departure of the principal accounting officer.